Health Education Approach to Lung Screening
HEALS
2 other identifiers
interventional
675
1 country
3
Brief Summary
Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Oct 2023
Typical duration for not_applicable lung-cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedStudy Start
First participant enrolled
October 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
March 16, 2026
March 1, 2026
3.5 years
September 30, 2023
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of study patients who complete lung cancer screening (LCS) through the patient navigation process
Evaluate the impact of the patient navigation program on the number of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT).
2 weeks to 4 months following day 1, varies by participant
Secondary Outcomes (6)
Assess the feasibility and acceptability of the patient navigation program
Day 1
Assess the feasibility and acceptability of the patient navigation program
2 weeks to 4 months following day 1, varies by participant
Assess the impact of the patient navigation program on patient health-related quality of life at baseline.
Day 1
Assess the impact of the patient navigation program on patient health-related quality of life after navigation intervention.
2 weeks to 4 months following day 1, varies by participant
Assess the impact of the patient navigation program on patient financial distress
Day 1
- +1 more secondary outcomes
Study Arms (1)
Patient Navigation
EXPERIMENTALCentralized patient navigators will be trained to help patients navigate the clinical, logistical, and financial aspects of LCS. Navigators employ case management approaches based on social work principles. The experience of patient navigation will be tailored to the individual participant
Interventions
Navigation will address the following 4 domains of barriers to screening: * Individual * Organizational * Economic * Sociocultural At the first visit, navigators will assess the participant's barriers in each of these domains. Any follow-up visits, if necessary, will be used to help the participant overcome these barriers to screening
Eligibility Criteria
You may qualify if:
- Meets current USPSTF guidelines for lung cancer screening (LCS)
- pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
- One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.
- Currently smokes or has quit smoking within the past 15 years
- Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
- Willing to complete all navigation-related study activities
- Able to understand and the willingness to sign a written informed consent document
You may not qualify if:
- Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
- Has undergone a previous lung cancer screening
- Inability to speak English
- Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stand Up To Cancercollaborator
- Virginia Commonwealth Universitylead
Study Sites (3)
University of North Carolina-Chapel Hill
Carrboro, North Carolina, 27510, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa Sheppard, PhD
Virginia Commonwealth University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2023
First Posted
October 6, 2023
Study Start
October 10, 2023
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Currently there is not a plan to share with other researchers not working on the protocol.